title: Large-scale prospective T cell function assays in shipped, unfrozen blood samples: experiences from the multicenter TRIGR trial.
abstract: Broad consensus assigns T lymphocytes fundamental roles in inflammatory, infectious, and autoimmune diseases. However, clinical investigations have lacked fully characterized and validated procedures, equivalent to those of widely practiced biochemical tests with established clinical roles, for measuring core T cell functions. The Trial to Reduce Insulin-dependent diabetes mellitus in the Genetically at Risk (TRIGR) type 1 diabetes prevention trial used consecutive measurements of T cell proliferative responses in prospectively collected fresh heparinized blood samples shipped by courier within North America. In this article, we report on the quality control implications of this simple and pragmatic shipping practice and the interpretation of positive- and negative-control analytes in our assay. We used polyclonal and postvaccination responses in 4,919 samples to analyze the development of T cell immunocompetence. We have found that the vast majority of the samples were viable up to 3 days from the blood draw, yet meaningful responses were found in a proportion of those with longer travel times. Furthermore, the shipping time of uncooled samples significantly decreased both the viabilities of the samples and the unstimulated cell counts in the viable samples. Also, subject age was significantly associated with the number of unstimulated cells and T cell proliferation to positive activators. Finally, we observed a pattern of statistically significant increases in T cell responses to tetanus toxin around the timing of infant vaccinations. This assay platform and shipping protocol satisfy the criteria for robust and reproducible long-term measurements of human T cell function, comparable to those of established blood biochemical tests. We present a stable technology for prospective disease-relevant T cell analysis in immunological diseases, vaccination medicine, and measurement of herd immunity.
authors: Pediatric Epidemiology Center, Department of Pediatrics, College of Medicine, University of South Florida, Tampa, Florida, USA.
authors: David
authors: D
authors: Hadley
authors: Roy K
authors: RK
authors: Cheung
authors: Dorothy J
authors: DJ
authors: Becker
authors: Rose
authors: R
authors: Girgis
authors: Jerry P
authors: JP
authors: Palmer
authors: David
authors: D
authors: Cuthbertson
authors: Jeffrey P
authors: JP
authors: Krischer
authors: Hans-Michael
authors: HM
authors: Dosch
mesh_terms: D001769:Blood / Q000276:immunology*; D049109:Cell Proliferation; D002470:Cell Survival; D002648:Child; D002675:Child, Preschool; D015331:Cohort Studies; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D009656:North America; D011446:Prospective Studies; D013048:Specimen Handling / Q000379:methods*; D013601:T-Lymphocytes / Q000276:immunology* / Q000502:physiology*; D013997:Time Factors